All In MedTech

FDA Clearance Tracker · P000040-S042

Genesys HTA System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 26, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P000040-S042
Device name
Genesys HTA System
Applicant location
Jacksonville, FL
Received
Apr 27, 2022
Decided
May 26, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P000040

Device type

Device class
Class III

Every decision under product code MNB

FDA's approval statement

As written in FDA's record.

Approval for manufacturing sites located at Life Science Outsourcing, Inc, 830 Challenger Street, Brea, CA 92821 and sterilization services at STERIS Applied Sterilization Technologies, 43425 Business Park Drive, Temecula, CA 92590.

Source documents

Other decisions for Axora Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.